These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24614707)

  • 41. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
    Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
    [No Abstract]   [Full Text] [Related]  

  • 43. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.
    Butler JR; Ahmad SA; Katz MH; Cioffi JL; Zyromski NJ
    HPB (Oxford); 2016 Apr; 18(4):305-11. PubMed ID: 27037198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
    Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
    Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients.
    Nitschke P; Volk A; Welsch T; Hackl J; Reissfelder C; Rahbari M; Distler M; Saeger HD; Weitz J; Rahbari NN
    Ann Surg; 2017 Jun; 265(6):1219-1225. PubMed ID: 27280512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin.
    Campbell F; Smith RA; Whelan P; Sutton R; Raraty M; Neoptolemos JP; Ghaneh P
    Histopathology; 2009 Sep; 55(3):277-83. PubMed ID: 19723142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Liu DN; Lv A; Tian ZH; Tian XY; Guan XY; Dong B; Zhao M; Hao CY
    Oncotarget; 2017 Jan; 8(5):7766-7776. PubMed ID: 27999192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
    Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial.
    Sabater L; Cugat E; Serrablo A; Suarez-Artacho G; Diez-Valladares L; Santoyo-Santoyo J; Martín-Pérez E; Ausania F; Lopez-Ben S; Jover-Navalon JM; Garcés-Albir M; Garcia-Domingo MI; Serradilla M; Pérez-Aguirre E; Sánchez-Pérez B; Di Martino M; Senra-Del-Rio P; Falgueras-Verdaguer L; Carabias A; Gómez-Mateo MC; Ferrandez A; Dorcaratto D; Muñoz-Forner E; Fondevila C; Padillo J
    Ann Surg; 2019 Nov; 270(5):738-746. PubMed ID: 31498183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease.
    Turrini O; Gilabert M; Ewald J; Moutardier V; Delpero JR; Iovanna JL
    J Visc Surg; 2017 Oct; 154(5):329-333. PubMed ID: 28844705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of surgical margins in pancreatic cancer.
    Ethun CG; Kooby DA
    J Surg Oncol; 2016 Mar; 113(3):283-8. PubMed ID: 26603829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
    Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
    Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP;
    Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.